Zofran and Nulytely drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zofran (ondansetron hydrochloride) and Nulytely (polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride). Common drug interactions include rapid correction of hyponatraemia among females and general physical health deterioration among males.

The phase IV clinical study analyzes what interactions people have when they take Zofran and Nulytely. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.

What is Nulytely?

Nulytely has active ingredients of polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride. eHealthMe is studying from 1,377 Nulytely users. Check the latest studies of Nulytely.



On Jul, 25, 2026

35 people who take Zofran and Nulytely together, and have interactions are studied.

Zofran and Nulytely drug interactions.

What are the common drug interactions of Zofran and Nulytely, by gender? *:

female:

  1. Rapid correction of hyponatraemia (rapid correction of abnormally low concentrations of sodium ions in the circulating blood)
  2. General physical health deterioration (weak health status)
  3. Thirst
  4. Blood sodium decreased
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Diarrhoea
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Joint dislocation (a joint position is changed from normal position)
  9. Delirium (wild excitement)
  10. Hallucination (an experience involving the perception of something not present)

male:

  1. General physical health deterioration (weak health status)
  2. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  3. Liver disorder (liver diseases)
  4. Renal failure (kidney dysfunction)
  5. Respiratory tract infection
  6. Anaemia (lack of blood)
  7. Aspartate aminotransferase increased
  8. Atrial tachycardia (rhythm disturbance that arises in the atria)
  9. Bacteraemia (presence of bacteria in the blood)
  10. Bilirubin conjugated increased

What are the common drug interactions of Zofran and Nulytely, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Intestinal resection
  2. Pouchitis (inflammatory bowel disease)

20-29:

  1. Anal abscess
  2. Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
  3. Infusion related reaction
  4. Lung transplant rejection (failure of lung transplant)
  5. Quadriplegia (a four limb paralysis)

30-39:

n/a

40-49:

  1. Paresis (a condition of muscular weakness)

50-59:

  1. Chronic kidney disease
  2. Diarrhoea
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Hypophagia (reduced food intake)
  6. Incontinence (lack of moderation or self-control)
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Renal failure (kidney dysfunction)
  9. Renal tubular necrosis (death of kidney tubules)

60+:

  1. General physical health deterioration (weak health status)
  2. Decreased appetite
  3. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  4. Blood sodium decreased
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Confusional state
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Joint dislocation (a joint position is changed from normal position)
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Platelet count decreased

What are the existing conditions these people have? *

  1. Pain: 16 people, 45.71%
  2. Bone Pain: 9 people, 25.71%
  3. Multiple Myeloma (cancer of the plasma cells): 9 people, 25.71%
  4. Nausea And Vomiting: 7 people, 20.00%
  5. High Blood Pressure: 6 people, 17.14%
  6. Constipation: 5 people, 14.29%
  7. Sleep Disorder: 4 people, 11.43%
  8. Depression: 4 people, 11.43%
  9. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 11.43%
  10. Cerebral Disorder (brain disease): 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Zofran and Nulytely?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zofran and Nulytely:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nulytely:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zofran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nulytely and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ondansetron hydrochloride and polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride (the active ingredients of Zofran and Nulytely, respectively), and Zofran and Nulytely (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: